Medical Product Alerts

The World Health Organization's Medical Product Alerts are designed to warn Member States and populations of the existence of dangerous medical products and encourage increased vigilance and appropriate regulatory action by National Medicines Regulatory Authorities/ Ministries of Health to protect populations and supply chains.

Credit: artisteer
i
Credit: artisteer

Read WHO news alert calling for action to protect children from contaminated medicines

 

Please see below for the latest WHO Medical Product Alerts:

Alert N°8/2023Substandard (contaminated) syrup and suspension medicines identified in the WHO Regions of the Americas, Eastern Mediterranean, South-East Asia and Western Pacific

Alert N°7/2023Falsified DEFITELIO (defibrotide) identified in the WHO Regions of Europe and South-East Asia

Alert N°6/2023Substandard (contaminated) syrup medicines identified in WHO Region of the Eastern Mediterranean

Alert N°5/2023 - Substandard (contaminated) syrup medicines identified in WHO Region of Africa

Alert N°4/2023 - Substandard (contaminated) syrup medicines identified in WHO Region of the Western Pacific

Alert N°3/2023Falsified DEFITELIO (defibrotide sodium) identified in the WHO Regions of Europe and the Eastern Mediterranean

Alert N°2/2023 - Tetracycline Hydrochloride Ophthalmic Ointment USP 1%

Alert N°1/2023 - Substandard (contaminated) liquid dosage medicines identified in WHO European Region

Alert N°8/2022 - Substandard (contaminated) METHOTREX 50mg CRM:0402908

Alert N°7/2022 - Substandard (contaminated) paediatric liquid dosage medicines identified in WHO region of South-East Asia

Alert N°6/2022 - Substandard (contaminated) paediatric medicines identified in WHO region of Africa

Alert N°5/2022 - Falsified DIPRIVAN (Propofol) identified in WHO region of the Americas

Alert N°4/2022 - the Falsified Dysport identified in the WHO Regions of Europe and Eastern Mediterranean

Alert N°3/2022 - Falsified Intratect (Human normal immunoglobulin) identified in the WHO Regions of the Americas, Eastern Mediterranean and South-East Asia

Alert N°2/2022 - Falsified DESREM (Remdesivir) identified in the WHO Regions of the Americas and South-East Asia

Alert N° 9/2021 - Falsified Soliris identified in WHO regions of the Americas, Europe and South East Asia

Alert N° 8/2021 - Falsified Combiart identified in WHO region of Africa

Alert N° 7/2021 Falsified COVID-19 VACCINE AstraZeneca identified in WHO region of the Eastern Mediterranean

Alert N° 6/2021 Falsified Pfizer-BioNTech COVID-19 Vaccine identified in WHO region of the Eastern Mediterranean

Alert N° 5/2021Falsified COVISHIELD vaccine identified in the WHO regions of Africa and South- East Asia

Alert N° 4/2021 - Falsified Remdesivir identified in WHO region of the Americas

Alert N° 3/2021 - Falsified CYTOTEC identified in WHO region of Africa

Alert N° 2/2021 Falsified COVID-19 Vaccine BNT162b2 identified in the WHO region of the Americas

Alert N°1/2021 - Falsified VITAMIN A (retinol) identified in WHO region of Africa

Alert N°7/2020 - Falsified HARVONI (Ledipasvir/sofosbuvir) identified in the WHO regions of the Americas and Europe

Alert N° 6/2020 - Falsified Fluzone® Quadrivalent Influenza Vaccine identified in WHO region of the Americas 

Alert N° 5/2020Falsified and contaminated Defibrotide identified in WHO regions of Western Pacific, Europe and Eastern Mediterranean

Alert N°4/2020 Falsified chloroquine products circulating in the WHO regions of Africa and Europe

Alert N° 3/2020Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

Alert N° 2/2020Falsified HIV rapid diagnostic test circulating in the WHO regions of the Americas and Africa

Alert N°1/2020 Falsified antimalarials in Nigeria, Cameroon and Chad

Alert N°11/2019Falsified Amoxicillin + Clavulanic Acid products circulating in Haiti

Alert N°10/2019Falsified Quinine Bisulphate circulating in Uganda and Quinine Sulphate circulating in Central African Republic and Chad

Alert N°9/2019 - Falsified Augmentin found in Uganda and Kenya 

Alert N° 8/2019Falsified Rabies Vaccines and Anti-Rabies Serum circulating in the Philippines

Alert N° 7/2019Falsified meglumine antimoniate ampoules in Iran and Pakistan

Alert N°6/2019 - Falsified hydrochlorothiazide (containing glibenclamide) in Cameroon

Alert N°5/2019 - Falsified meningitis vaccines circulating in Niger

Alert N°4/2019 - Falsified oral cholera vaccines circulating in Bangladesh

Alert N° 3/2019 - Falsified ICLUSIG available at patient level in Asia and traded globally

Alert N° 2/2019 - Falsified ICLUSIG traded globally

Alert N° 1/2019  - Falsified Rabies Vaccines circulating in the Philippines

Alert N° 3/2018 - Falsified Hepatitis B Vaccines circulating in Uganda

Alert N° 2/2018 - Falsified “Augmentin” circulating in Cameroon

Alert N° 1/2018 - Falsified cefixime products circulating in the Democratic Republic of the Congo

Alert N° 4/2017 - Falsified Penicillin V circulating in Cameroon

Alert N° 3/2017 - Falsified Avastin (bevacizumab) and Sutent (sunitinib malate) circulating in East Africa

Alert N° 2/2017 - Falsified Quinine Sulphate circulating in Africa

Alert N° 1/2017 - Falsified Meningococcal ACWY Vaccine circulating in West Africa 

Alert N° 4/2016: Quinine Sulphate - Falsified Quinine Sulphate circulating in West and Central Africa

Alert N° 3/2016: LEDSO capsules, DAKAVIR - Falsified Hepatitis C medicines circulating in South East Asia

Alert N° 2/2016: AMARIL - Falsified "AMARIL" yellow fever vaccines circulating in South East Asia

Alert N° 1/2016: Phenobarbitone - Falsified phenobarbitone tablets circulating in West Africa

 

For further information on Medical Product Alerts, please visit the WHO website

Visit our 'Useful resources' page for details of organisations involved in tackling the global problem of falsified and substandard medicines.